Safety study of KR23248 in healthy adults
Part of Mental health clinical trials.
This is an early-stage study testing a new experimental drug called KR23248 in healthy volunteers to see if it is safe and how the body processes it. Researchers want to understand potential side effects and how the drug moves through your system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 45 years old
- Have a healthy weight (BMI 18.5–28.0) and weigh at least 50 kg if male or 45 kg if female
- Be in good overall health with no serious medical conditions
- Able to follow strict rules about diet, medications, alcohol, and smoking during the study
- Willing to have blood tests, heart monitoring, and stay in the clinic for the trial period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy men a single dose of a drug with a tiny amount of radioactivity to see how it leaves the body through urine and stool. It helps researchers understand how the drug is processed.
This trial tests if a new drug called VV119 is safe and how it works in the body. It is for healthy volunteers and for people who have had schizophrenia for at least a year and are currently having worsening symptoms.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.